Edition:
United States

Cryosite Ltd (CTE.AX)

CTE.AX on Australia Stock Exchange

0.14AUD
--
Change (% chg)

-- (--)
Prev Close
$0.14
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
35,839
52-wk High
$0.20
52-wk Low
$0.13

Chart for

About

Cryosite Limited is a biotechnology and biologics logistics company. The Company is engaged in cryopreservation and expansion of mesenchymal stem cells (MSCs) from umbilical cord tissue. The Company operates through two segments: Individualised Consumer Biologics, and Scientific Processing and Logistics. The Individualised... (more)
No analyst recommendations are available for .

Overall

Beta: 0.89
Market Cap(Mil.): $6.33
Shares Outstanding(Mil.): 46.86
Dividend: 0.00
Yield (%): 7.41

Financials

  Industry Sector
P/E (TTM): -- 29.54 17.08
EPS (TTM): -- -- --
ROI: -- 6.50 11.26
ROE: -- 10.26 15.09

BRIEF-Cryosite says ACCC to review proposed license and sale of certain cord blood and tissue assets​

* Australian competition & consumer commission to review proposed license and sale of certain cord blood and tissue assets​

Aug 03 2017

BRIEF-Cryosite announces resignation of ceo

* Andrew Shine has tendered his resignation as ceo Source text for Eikon: Further company coverage:

May 18 2017

Earnings vs. Estimates

No consensus analysis data available.